GW Pharmaceuticals | GWPH


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Acadia Pharmaceuticals 20.95 1.55 7.99% -57.54%
Acorda Therapeutics 4.71 -0.21 -4.27% 488.68%
Adamas Pharmaceuticals 5.02 -0.41 -7.55% 45.09%
Aerie Pharmaceuticals 17.12 0.28 1.66% 18.48%
Agios Pharmaceuticals 55.10 1.83 3.44% 40.17%
ALKERMES 21.20 -0.05 -0.23% 44.76%
Alnylam Pharmaceuticals 132.10 -0.57 -0.43% -6.61%
Alexion Pharmaceuticals 169.86 -0.05 -0.03% 75.26%
Biogen 272.11 0.54 0.20% -13.34%
Bluebird Bio 29.67 0.46 1.57% -50.01%
BioMarin Pharmaceutical 78.61 0.93 1.20% -14.55%
Clovis Oncology 5.67 -0.19 -3.24% -34.22%
Flexion Therapeutics 7.39 -0.07 -0.94% -32.08%
GW Pharmaceuticals 218.96 -0.32 -0.15% 108.53%
Heron Therapeutics 16.72 -0.12 -0.71% 13.59%
Intercept Pharmaceuticals 17.01 -2.03 -10.66% -79.95%
YTE 82.31 1.03 1.27% -14.68%
Ionis Pharmaceuticals 37.33 -2.50 -6.27% -29.84%
Moderna Inc 159.00 -2.11 -1.30% 198.93%
Neurocrine Biosciences 89.43 -2.17 -2.37% -17.91%
Puma Biotechnology 9.68 0.04 0.41% -2.02%
Prothena 23.66 -0.45 -1.87% 111.06%
PTC Therapeutics 40.33 -0.55 -1.35% -14.03%
Ultragenyx Pharmaceutical 115.71 9.70 9.15% 83.32%
Regeneron Pharmaceuticals 498.68 16.26 3.37% -10.92%
Sarepta Therapeutics 74.61 1.84 2.53% -39.64%
Vertex Pharmaceuticals 213.16 -0.71 -0.33% -21.05%
Zogenix 17.53 0.05 0.29% -32.45%

Indexes Price Day Year
NASDAQ 13632 50.42 0.37% 51.82%

GWPH:US
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
PE Price to Earnings
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors